Navigation Links
EntreMed Commences Phase 2 Study with MKC-1 in Pancreatic Cancer
Date:12/4/2007

hown to inhibit mitotic spindle formation, prevent chromosome segregation in the M-phase (mitosis) of the cell cycle, and induce apoptosis.

Carolyn F. Sidor, M.D., M.B.A., EntreMed Vice President and Chief Medical Officer, commented on the study, "Pancreatic cancer patients continue to need more effective and better tolerated treatment options. MKC-1 has shown good activity in preclinical testing against pancreatic tumors, supporting its use in this patient population. Positive results from this clinical trial will provide the basis for designing future randomized Phase 2 studies. With this clinical trial initiation, we are now evaluating MKC-1 as a single agent or in combination in patients with pancreatic cancer, metastatic breast cancer, non- small cell lung cancer (NSCLC), and leukemia."

About Pancreatic Cancer

Pancreatic cancer is the abnormal cell growth in the tissue of the pancreas. The pancreas is an organ about six inches in length which is located behind the stomach, next to the small intestine. The pancreas produces enzymes that aide in the digestion and absorption of food. Unless pancreatic cancer is detected early, it is difficult to control. At the present time, there is no effective screening for pancreatic cancer and, because the pancreas is hidden by other organs, it is difficult to diagnosis. Pancreatic cancer is the fourth leading cause of cancer death in the United States. The American Cancer Society estimates that approximately 37,000 Americans will be diagnosed with cancer of the pancreas in 2007, resulting in approximately 33,000 deaths.

About EntreMed

EntreMed, Inc. is a clinical-stage pharmaceutical company developing therapeutic candidates primarily for the treatment of cancer and inflammation. Panzem(R) NCD (2-methoxyestradiol or 2ME2) is currently in multiple Phase 2 clinical trials for cancer. MKC-1, an oral cell-cycle regulator, is in multiple Phase 1 and 2 studies for cancer. ENMD-1198, a novel tubul
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
2. EntreMed Raises $20 Million to Support Clinical Development Program
3. EntreMed Reports Phase 1 PK and Preclinical Efficacy Results for ENMD-1198
4. EntreMed Shows Increased Survival With MKC-1 in Preclinical Renal Cell Cancer Model
5. Memory Pharmaceuticals Commences Phase 1 Clinical Program for R4996/MEM 63908
6. Sinovac Commences Vaccination on Volunteers for Phase II Clinical Trial on Pandemic Influenza H5N1 Vaccine
7. Sunesis Pharmaceuticals Commences Clinical Trials of SNS-595 and SNS-314
8. Pharmasset Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV
9. Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C
10. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
11. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... 22, 2014 Auxilium Pharmaceuticals, Inc. (NASDAQ: ... today announced that its Board of Directors (the ... proposal from Endo International plc ("Endo") and, after ... has unanimously determined it is not a superior ... agreement with QLT Inc. ("QLT") and has unanimously ...
(Date:9/19/2014)... , Sept. 19, 2014 Medical ... forging relationships with key opinion leaders (KOLs) who ... competition. Despite the critical nature of the MSL ... challenges, including altering the landscape for creating and ... According to research, the oversight responsibility for the ...
(Date:9/19/2014)... , Sept. 19, 2014 "Copay ... inflate sales of brand drugs among patients with ... according to a new report  from the ... of the Inspector General (OIG). Federal anti-kickback laws prohibit ... that are subsidized by the federal government. ...
Breaking Medicine Technology:Auxilium Provides Transaction Update 2Auxilium Provides Transaction Update 3Auxilium Provides Transaction Update 4Auxilium Provides Transaction Update 5Auxilium Provides Transaction Update 6Role of Medical Science Liaisons Shifting in Healthcare Industry 2PCMA: New OIG Report Cites Drug Manufacturer "Copay Coupon" Use in Medicare Part D 2
... Philips Respironics applauds the efforts of the Centers ... about an important public health issue -- chronic sleep ... to monitor state-by-state differences in sleeplessness is a milestone ... , As a long-time educator, industry leader and ...
... 6 Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX ) will hold ... EST to discuss the third quarter 2009 financial results and business ... Officer of the Company, will host the call. Keryx will ... to be issued prior to the call. , In order to ...
Cached Medicine Technology:Statement by Don Spence, CEO, Philips Home Healthcare Solutions, Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation 2Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2009 Financial Results on Tuesday, November 10, 2009 at 8:30 a.m. EST 2
(Date:9/22/2014)... 2014 The report segments the ... user, and geography. The equipment segment accounted for ... market, by product. However, the accessories segment is ... the forecast period, owing to the rising demand ... and ultrasound segments are the fastest-growing segments in ...
(Date:9/22/2014)... participate in athletics will be asked to sign a ... ensure parents are confident about handling the injury, according ... Hospital National Poll on Children,s Health. , In the ... and high school children surveyed reported participation in some ... read a brochure or online information, 17% have ...
(Date:9/22/2014)... and leadership of Senators Sherrod Brown (D-Ohio) and ... primary care services were lauded yesterday by the ... organizations, representing internal medicine and related subspecialties. ... for introducing the Ensuring Access to Primary Care ... will extend current-law payment rates under Medicaid for ...
(Date:9/22/2014)... 2014) The success of a colonoscopy is closely ... often resulting in missed precancerous lesions, according to new ... on Colorectal Cancer. Additionally, poor bowel cleansing can result ... to 20 to 25 percent of all colonoscopies are ... "When prescribing bowel preparation for their patients, health-care professionals ...
(Date:9/22/2014)... laser weapons, the Office of Naval Research (ONR) this ... Day Marine exposition that will prepare Marines as they ... ONR program officers will be in Booth No. 2305 ... Base Quantico, to discuss how their research contributes to ... austere and lethal." , ONR,s Expeditionary Maneuver Warfare and ...
Breaking Medicine News(10 mins):Health News:6.8% CAGR for Physiotherapy Equipment Market Globally to 2019 Says a New Research Report Available at ReportsnReports.com 2Health News:6.8% CAGR for Physiotherapy Equipment Market Globally to 2019 Says a New Research Report Available at ReportsnReports.com 3Health News:6.8% CAGR for Physiotherapy Equipment Market Globally to 2019 Says a New Research Report Available at ReportsnReports.com 4Health News:6.8% CAGR for Physiotherapy Equipment Market Globally to 2019 Says a New Research Report Available at ReportsnReports.com 5Health News:Some concussion education more useful than others, parents say 2Health News:Broad physician coalition urges Congress to extend Medicaid pay parity 2Health News:Good bowel cleansing is key for high-quality colonoscopy 2Health News:Good bowel cleansing is key for high-quality colonoscopy 3Health News:Modern Day Marine: ONR features technology for marines of the future 2
... CREEK, Calif., March 7 Longs Drug,Stores Corporation ... J. Vasos has been,named executive vice president and ... who has left the Company. Vasos will,be responsible ... Vasos joined Longs in 2001 as senior ...
... available in Spanish . , Researchers from the ... the University of Granada have carried out a ... come to is that an efficient response in primary care ... caused by three of the most frequent pathologies in older ...
... health care to be released at forum, LOS ... MAYA:, What: MAYA along with leading business and ... Better Through Communication" to,seek new ways to promote better ... and the Latino Issues Forum will release the,findings of ...
... IPC The,Hospitalist Company, Inc. (Nasdaq: IPCM ), a ... hospitalist medicine services,announced today that it will report results ... 20, 2008, before the market opens., A conference ... a.m. ET,(6:00 a.m. PT) on March 20, 2008 and ...
... Western Reserve University School of Medicine researchers published a ... Journal of Human Genetics identifying the hereditary components of ... in a Genome-wide Scan: Results from the Colon Neoplasia ... families with CRC and colon polyps in the country. ...
... physical, mental scores, study finds , , FRIDAY, March 7 ... families boosts children,s physical and mental development, a U.S. ... California, Berkeley found that children in low-income families in ... a government-run conditional cash transfer program were taller, less ...
Cached Medicine News:Health News:Longs Drug Stores Announces Todd Vasos Executive Vice President and Chief Operating Officer 2Health News:An efficient response in primary care would reduce the use of hospitals by elderly people 2Health News:Nationwide Telephone News Briefing for U.S. Health Disparities Forum 2Health News:IPC The Hospitalist Company, Inc. to Report Fourth Quarter and Year-End 2007 Financial Results 2Health News:Case Western Reserve University researchers identify colorectal cancer gene 2Health News:Government Assistance Linked to Better Child Development 2
... dedicated to the principles of excellence and ... committed to aiding the clinician in early ... design of profiles and panels that provide ... tests. These tests assist to resolve the ...
ChildLab is a service of Children's Hospital, Columbus Ohio...
Millenova Immunology Laboratories is a reference laboratory dedicated to the diagnosis of immunologic causes of reproductive failure, infertility and recurrent pregnancy loss....
Marquette General Health System Reference Laboratory provides a full range of testing including, Chemistry, Hematology, Coagulation, Urinalysis, Microbiology, Cytology, Anatomic Pathology, Flow Cytom...
Medicine Products: